These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1430 related articles for article (PubMed ID: 12775192)

  • 21. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V; Winterhoff H; Herkenham M
    Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Hypericum perforatum (St. John's wort) on passive avoidance in the rat: evaluation of potential neurochemical mechanisms underlying its antidepressant activity.
    Misane I; Ogren SO
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S89-97. PubMed ID: 11518084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. John's wort in behavioral paradigms of despair.
    Kulkarni SK; Akula KK; Deshpande J
    Pharmacology; 2012; 89(1-2):83-90. PubMed ID: 22343362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. St. John's wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces 3-adrenoceptor numbers on cultured rat brain cells.
    Kientsch U; Bürgi S; Ruedeberg C; Probst S; Honegger UE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S56-60. PubMed ID: 11518078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
    Bouron A; Lorrain E
    Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice.
    Kumar A; Singh A
    Planta Med; 2007 Oct; 73(13):1358-64. PubMed ID: 17918039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.).
    Nathan P
    Mol Psychiatry; 1999 Jul; 4(4):333-8. PubMed ID: 10483049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. St John's wort (Hypericum perforatum) in major depression.
    Shelton RC
    J Clin Psychiatry; 2009; 70 Suppl 5():23-7. PubMed ID: 19909690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression.
    Bukhari IA; Dar A
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1082-9. PubMed ID: 23661522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavonoids of St. John's Wort reduce HPA axis function in the rat.
    Butterweck V; Hegger M; Winterhoff H
    Planta Med; 2004 Oct; 70(10):1008-11. PubMed ID: 15490333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. St John's wort and depression: slight efficacy at best, many drug interactions.
    Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. About the cover: St. John's wort.
    J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
    Butterweck V; Winterhoff H; Herkenham M
    Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropharmacology of St. John's Wort (Hypericum).
    Bennett DA; Phun L; Polk JF; Voglino SA; Zlotnik V; Raffa RB
    Ann Pharmacother; 1998 Nov; 32(11):1201-8. PubMed ID: 9825087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological studies in an herbal drug combination of St. John's Wort (Hypericum perforatum) and passion flower (Passiflora incarnata): in vitro and in vivo evidence of synergy between Hypericum and Passiflora in antidepressant pharmacological models.
    Fiebich BL; Knörle R; Appel K; Kammler T; Weiss G
    Fitoterapia; 2011 Apr; 82(3):474-80. PubMed ID: 21185920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
    Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
    Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.